Larson Financial Group LLC Biotechnology

Larson Financial Group LLC

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
INVA Innoviva, Inc.	$1.33B	$0 0.0% of portfolio	10	Q2 2024 New
RARE Ultragenyx Pharmaceutical Inc.	$3.25B	$0 0.0% of portfolio	17	Q2 2024 New
LXRX Lexicon Pharmaceuticals, Inc.	$153M	$0 0.0% of portfolio	100	Q2 2024 New
HRMY Harmony Biosciences Holdings, Inc.	$1.94B	$0 0.0% of portfolio	4	Q2 2024 New
VERU Veru Inc.	$50.5M	$0 0.0% of portfolio	1,275	Q4 2022 New
RGNX Regenxbio Inc.	$416M	$0 0.0% of portfolio	4	Q2 2024 New
XNCR Xencor Inc	$1.42B	$0 0.0% of portfolio	5	Q2 2024 New
TECH Bio Techne Corp	$2.7B	$0 0.0% of portfolio	4	Q3 2024 New
EDIT Editas Medicine, Inc.	$166M	$0 0.0% of portfolio	244	Q2 2024 Reduced 67.2%
VXRT Vaxart, Inc.	$77.2M	$0 0.0% of portfolio	156	Q2 2021 Added 23.81%
VERV Verve Therapeutics, Inc.	$273M	$0 0.0% of portfolio	51	Q3 2024 Reduced 80.38%
CORT Corcept Therapeutics Inc	$6.01B	$0 0.0% of portfolio	8	Q2 2024 New
CHRS Coherus Bio Sciences, Inc.	$85.5M	$0 0.0% of portfolio	147	Q3 2024 Reduced 99.79%
OMER Omeros Corp	$378M	$0 0.0% of portfolio	150	Q4 2019 New
IONS Ionis Pharmaceuticals Inc	$5.02B	$0 0.0% of portfolio	18	Q2 2024 New
VIR Vir Biotechnology, Inc.	$894M	$0 0.0% of portfolio	16	Q2 2024 New
IMCR Immunocore Holdings PLC	$1.42B	$0 0.0% of portfolio	10	Q4 2023 Reduced 23.08%
ARCT Arcturus Therapeutics Holdings Inc.	$430M	$0 0.0% of portfolio	1	Q3 2024 New

Get notified when there are updates to the investment portfolio of Larson Financial Group LLC, based on Form 13F filings with the SEC.

Stay updated on Larson Financial Group LLC with notifications on news.